MedTrace Logo

Povidone-iodine Against Sodium Hypochlorite as Skin Antiseptics

NCT00738543 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2013-06-24

Study results available
· View outcomes & findings →

Summary

The investigators have few options for skin antisepsis. Alternatives for povidone-iodine, which is the most commonly used agent, are costly or ineffective. To have more options, this study is needed. The investigators want to know if there are difference between the use of 10% sodium hypochlorite or 10% povidone-iodine for skin antisepsis.

Conditions

  • Healthy Volunteers

Interventions

OTHER

WHOLE GROUP OF 48 VOLUNTEERS

Two antiseptics (10% povidone iodine and 10% sodium hypochlorite) and one control were tested as skin antiseptics. The intervention consisted of preparing the skin with the antiseptic or the control. The areas were approximately 25 cm2 on the forearm for each antiseptic or control. The antiseptic or control were applied in an outward circular motion using a swab that was soaked with the solution. The solution was then kept on the skin for 60 seconds before the bacterial culture was conducted. All volunteers were instructed to continue the use of neutral soap and shampoo without antiseptics during the follow-up period.

Sponsors & Collaborators

  • Concejo de Ciencia y Tecnología del Estado de Guanajuato

    collaborator UNKNOWN

  • Pisa SA de CV

    collaborator UNKNOWN

  • Universidad de Guanajuato

    lead OTHER

Principal Investigators

  • Alejandro E Macias, M. D. · Universidad de Guanajuato

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00738543 on ClinicalTrials.gov